Cargando…

Altitude does not protect against SARS‐CoV‐2 infections and mortality due to COVID‐19

Detalles Bibliográficos
Autores principales:	Cardenas, Laura, Valverde‐Bruffau, Valeria, Gonzales, Gustavo F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191172/ https://www.ncbi.nlm.nih.gov/pubmed/34110706 http://dx.doi.org/10.14814/phy2.14922

Ejemplares similares

The Pathogenicity of COVID-19 Is Independent of Increasing Altitude: The Case of Colombia
por: Valverde-Bruffau, Valeria Janice, et al.
Publicado: (2021)

Association between iron supplementation and the presence of diarrhoea in Peruvian children aged 6–59 months: analysis of the database of the Demographic and Family Health Survey in Peru (DHS, Peru), years 2009–2019
por: Valverde-Bruffau, Valeria Janice, et al.
Publicado: (2022)

Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia
por: Reina, Carlos, et al.
Publicado: (2021)

Comments on potential re-purposing of medicines against high-altitude illnesses towards SARS-CoV2: possibilities and pitfalls
por: Ahmad, Yasmin, et al.
Publicado: (2021)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

The role of masks and respirator protection against SARS-CoV-2
por: Wang, Qiang, et al.
Publicado: (2020)

Infectivity of SARS-CoV-2 and protection against reinfection in rats
por: Yu, Dandan, et al.
Publicado: (2022)

Is a COPD patient protected against SARS-CoV-2 virus?
por: Daubin, C., et al.
Publicado: (2021)

Antibody titers and protection against a SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
por: Hanrath, Aidan T., et al.
Publicado: (2020)

Lower mortality rates in those living at moderate altitude
por: Burtscher, Martin
Publicado: (2016)

How Does SARS-CoV-2 Fragment the QRS?
por: Finsterer, Josef
Publicado: (2022)

Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?
por: Arias-Reyes, Christian, et al.
Publicado: (2020)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021)

Does hand hygiene reduce SARS-CoV-2 transmission?
por: Yang, Chao
Publicado: (2020)

Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
por: Hsu, Lea, et al.
Publicado: (2021)

Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

Don’t blame the nails for SARS-CoV-2 hospitalizations and mortality
por: Desai, Amar D., et al.
Publicado: (2022)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice
por: van Oosten, Linda, et al.
Publicado: (2022)

The SARS-CoV-2 Pandemic Does Not Absolve From Solid Medical Trade
por: Finsterer, Josef, et al.
Publicado: (2021)

Does the E gene provide additional information in SARS-CoV-2 PCR?()
por: Zóka, András, et al.
Publicado: (2021)

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
por: Scherlinger, Marc, et al.
Publicado: (2023)

Suggesting Ritonavir against COVID-19/SARS-CoV-2
por: Choudhury, Shuvasish, et al.
Publicado: (2020)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Autophagy: A self-guard against SARS-CoV-2
por: Silva, Rafael Cardoso Maciel Costa, et al.
Publicado: (2022)

Delayed hypersensitivity as a pathophysiological mechanism in cutaneous lesions due to SARS-CoV-2
por: Rafai, Mostafa, et al.
Publicado: (2020)

Does COVID-19 vaccination protect against pulmonary embolism?
por: Tantillo, Simona, et al.
Publicado: (2023)

Psychotropics drugs with cationic amphiphilic properties may afford some protection against SARS-CoV-2: A mechanistic hypothesis
por: Vaugeois, Jean-Marie
Publicado: (2020)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
por: Chang, Kai Chieh
Publicado: (2021)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022)

SARS-CoV-2 infection in children with febrile neutropenia
por: Flores, Victoria, et al.
Publicado: (2020)

High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
por: van Dam, Peter A., et al.
Publicado: (2020)

Taiwan can help—Community protection net: preventive effects of the Northern Taiwan Centralized Quarantine Center against SARS-CoV-2
por: Tsai, Y.-F., et al.
Publicado: (2021)

Sudden death in SARS-CoV-2 associated polyradiculitis is unlikely due to affection of the phrenic nerve
por: Finsterer, Josef
Publicado: (2022)

The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?
por: Dal Moro, Fabrizio, et al.
Publicado: (2020)

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
por: Tu, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_66lm6vp3p33oegs9044ocqnsph